Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.

Saved in:
Bibliographic Details
Title: Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.
Authors: Collier DA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Ferreira IATM; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Kotagiri P; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir RP; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Lim EY; Department of Medicine, University of Cambridge, Cambridge, UK., Touizer E; Division of Infection and Immunity, University College London, London, UK., Meng B; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Abdullahi A; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK., Elmer A; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Kingston N; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Graves B; NIHR Bioresource, Cambridge, UK., Le Gresley E; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Caputo D; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Bioresource, Cambridge, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, Cambridge, UK., Cortes-Acevedo P; Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico., Barcenas-Morales G; Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico., Linterman MA; Immunology Programme, Babraham Institute, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Davis C; MRC Centre for Virus Research, University of Glasgow, Glasgow, UK., Thomson E; MRC Centre for Virus Research, University of Glasgow, Glasgow, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., McKinney E; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. efm30@medschl.cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. efm30@medschl.cam.ac.uk., Doffinger R; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. rd270@medschl.cam.ac.uk., Wills M; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. mrw1004@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. mrw1004@cam.ac.uk., Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.
Corporate Authors: CITIID-NIHR BioResource COVID-19 Collaboration
Source: Nature [Nature] 2021 Aug; Vol. 596 (7872), pp. 417-422. Date of Electronic Publication: 2021 Jun 30.
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-021-03739-1